As of Jan 20
| +0.07 / +0.22%|
The 20 analysts offering 12-month price forecasts for Pfizer have a median target of 38.00, with a high estimate of 53.00 and a low estimate of 30.00. The median estimate represents a +19.61% increase from the last price of 31.77.
The current consensus among 23 polled investment analysts is to Hold stock in Pfizer. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.